/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Increase of beta-blocker dose and QT interval in heart failure - do we really know it all by heart? Results from CIBIS ELD study.
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Beta blockers
Session: Beta blockers
Beta-blockers and lipid profile in heart failure - statins as a dealmakers. Results from CIBIS ELD study.
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Beta blockers
Session: Beta blockers
Prevention of erectile dysfunction - sign of a good prognosis after acute myocardial infarction
Event: EuroPrevent 2017
Topic: Epidemiology, lipids
Session: Epidemiology/ Public health_Part 1
Influence of optimized beta-blocker therapy on diastolic dysfunction determined echocardiographically in heart failure patients
Event: EuroEcho-Imaging 2016
Topic: Assessment of diastolic function
Session: Assessment of morphology and function
Depression in chronic heart failure patients: to use beta-blockers and to cooperate with psychiatrists
Event: ESC Congress 2016
Topic: Heart failure, other
Session: Heart failure
Mid-regional pro-adrenomedullin as a prognostic indicator of 1-year mortality after acute heart failure. MOLITOR substudy.
Event: HEART FAILURE 2016
Topic: Biomarkers, other
Session: Biomarkers
CT-pro-endothelin-1 in heart failure patients with reduced and preserved ejection fraction - useful or waste of resources? MOLITOR substudy.
Event: HEART FAILURE 2016
Topic: Biomarkers, other
Session: Biomarkers
Clinical significance of growth differentiation factor-15 in patients with acute decompensated heart failure
Event: HEART FAILURE 2016
Topic: Prognosis (using biomarkers)
Session: Biomarkers
